Transactional, regulatory and competition work are three key strata running through the life sciences offering at Morgan, Lewis & Bockius UK LLP. Allison Soilihi co-heads the team and is well-placed to handle corporate life sciences work such as private equity transactions. Merger clearances and licensing mandates are firmly in the wheelhouse of fellow co-head Omar Shah. Paul Ranson‘s practice straddles commercial and regulatory matters, while Frances Murphy is an authority on EU and UK competition matters.
Legal 500 Editorial commentary
- Profile
- Social
Testimonials
Collated independently by Legal 500 research team.
‘Personable and extremely knowledgable, the team go out of their way to ensure they understand our business.’
‘Nicholas Moore and Humphrey Thomas are responsive and proactive and provide excellent advice before, during and after a potential acquisition. They are good at managing challenging stakeholders both internally and externally. ’
‘Deep personal expertise. Ability to right-size the approach to the size of the client.’
‘Excellent focus, competency and expert knowledge in the healthcare sector.’
‘Paul Ranson continues to operate at an extremely high level. Paul is always up to date, his knowledge, expertise, competency and practical experience set him apart from other professionals working in this very difficult and demanding sector.’
Key clients
- Advanz Pharma
- StoneCalibre
- Mercury Pharma (now owned by Advanz)
- Amdipharm (now Advanz)
- Focus Pharma
- AstraZeneca UK
- Former Focus Pharmaceuticals directors Messrs. Roland Brown, Mark Cresswell, and Graeme Duncan
- AMCo Pharma
- Replimune Group
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Omar Shah; Allison Soilihi
Other key lawyers
Paul Ranson; Frances Murphy; Tim Powell